Browse > Article
http://dx.doi.org/10.3904/kjim.2013.28.5.557

Clinical characteristics and follow-up of Korean patients with adrenal incidentalomas  

Cho, Yoon Young (Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Suh, Sunghwan (Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Joung, Ji Young (Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Jeong, Hyemin (Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Je, Dongmo (Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Yoo, Hongseok (Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Park, Taek Kyu (Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Min, Yong-Ki (Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Kim, Kwang-Won (Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Kim, Jae Hyeon (Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Publication Information
The Korean journal of internal medicine / v.28, no.5, 2013 , pp. 557-564 More about this Journal
Abstract
Background/Aims: We investigated the clinical characteristics and follow-up findings of subjects with adrenal incidentalomas in a single, tertiary-care hospital in South Korea. Methods: The study consisted of a retrospective analysis of 282 adrenal incidentaloma patients who underwent radiographic and endocrinological evaluations at Samsung Medical Center in Seoul, South Korea, between January 2004 and July 2011. Results: Most (86.2%) of the subjects were found to have nonfunctioning tumors. Functioning tumors were seen in 39 patients (13.8%). Among them, 28 (9.9%) had subclinical Cushing syndrome (SCS), six (2.1%) had pheochromocytoma, and five (1.8%) had primary hyperaldosteronism. Malignant adrenal tumors were discovered in three cases: two (0.7%) were primary adrenal cancers, and one (0.4%) was a secondary metastasis from a lung cancer. Significant risk factors for functional tumors were female gender (odds ratio [OR], 3.386; 95% confidence interval [CI], 1.611 to 7.117; p = 0.0013) and a noncontrast attenuation value of > 10 Hounsfield units (OR, 2.806; 95% CI, 1.231 to 6.397; p = 0.0141). During follow-up (mean, 22.5 months) of 72 of the patients, three (4.2%) developed hormonal changes due to functional tumors. One was confirmed as pheochromocytoma by histopathology, and the others were diagnosed with SCS and followed routinely without surgical intervention. No malignant transformation was found in these patients. Conclusions: Based on these findings, initial hormonal and radiographic evaluations for adrenal incidentalomas appear to be more important than follow-up tests because functional or malignant changes are rare.
Keywords
Adrenal gland neoplasms; Cushing syndrome; Pheochromocytoma; Aldosterone;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Mansmann G, Lau J, Balk E, Rothberg M, Miyachi Y, Bornstein SR. The clinically inapparent adrenal mass: update in diagnosis and management. Endocr Rev 2004;25:309-340.   DOI   ScienceOn
2 Bovio S, Cataldi A, Reimondo G, et al. Prevalence of adrenal incidentaloma in a contemporary computerized tomography series. J Endocrinol Invest 2006;29:298- 302.   DOI
3 Grumbach MM, Biller BM, Braunstein GD, et al. Management of the clinically inapparent adrenal mass ("incidentaloma"). Ann Intern Med 2003;138:424-429.   DOI   ScienceOn
4 Barzon L, Sonino N, Fallo F, Palu G, Boscaro M. Prevalence and natural history of adrenal incidentalomas. Eur J Endocrinol 2003;149:273-285.   DOI   ScienceOn
5 Mantero F, Terzolo M, Arnaldi G, et al. A survey on adrenal incidentaloma in Italy: Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab 2000;85:637-644.
6 Allolio B, Fassnacht M. Clinical review: adrenocortical carcinoma: clinical update. J Clin Endocrinol Metab 2006;91:2027-2037.   DOI   ScienceOn
7 Lenders JW, Eisenhofer G, Mannelli M, Pacak K. Phaeochromocytoma. Lancet 2005;366:665-675.   DOI   ScienceOn
8 Prinz RA, Brooks MH, Churchill R, et al. Incidental asymptomatic adrenal masses detected by computed tomographic scanning: is operation required? JAMA 1982;248:701-704.   DOI   ScienceOn
9 Geelhoed GW, Druy EM. Management of the adrenal "incidentaloma". Surgery 1982;92:866-874.
10 Ng VW, Ma RC, So WY, et al. Evaluation of functional and malignant adrenal incidentalomas. Arch Intern Med 2010;170:2017-2020.   DOI   ScienceOn
11 Jeong HS, Kim HJ, Kim HS, et al. Clinical characteristics for 132 patients with adrenal incidentaloma. J Korean Endocr Soc 2007;22:260-265.   DOI   ScienceOn
12 Murai M, Baba S, Nakashima J, Tachibana M. Management of incidentally discovered adrenal masses. World J Urol 1999;17:9-14.   DOI
13 Kim HY, Kim SG, Lee KW, et al. Clinical study of adrenal incidentaloma in Korea. Korean J Intern Med 2005;20:303-309.   DOI   ScienceOn
14 Kloos RT, Gross MD, Francis IR, Korobkin M, Shapiro B. Incidentally discovered adrenal masses. Endocr Rev 1995;16:460-484.
15 Yeh HC. Sonography of the adrenal glands: normal glands and small masses. AJR Am J Roentgenol 1980;135:1167-1177.   DOI
16 Abecassis M, McLoughlin MJ, Langer B, Kudlow JE. Serendipitous adrenal masses: prevalence, significance, and management. Am J Surg 1985;149:783-788.   DOI   ScienceOn
17 Barzon L, Scaroni C, Sonino N, et al. Incidentally discovered adrenal tumors: endocrine and scintigraphic correlates. J Clin Endocrinol Metab 1998;83:55-62.
18 Flecchia D, Mazza E, Carlini M, et al. Reduced serum levels of dehydroepiandrosterone sulphate in adrenal incidentalomas: a marker of adrenocortical tumour. Clin Endocrinol (Oxf ) 1995;42:129-134.   DOI   ScienceOn
19 Herrera MF, Grant CS, van Heerden JA, Sheedy PF, Ilstrup DM. Incidentally discovered adrenal tumors: an institutional perspective. Surgery 1991;110:1014-1021.
20 Barzon L, Fallo F, Sonino N, Boscaro M. Development of overt Cushing's syndrome in patients with adrenal incidentaloma. Eur J Endocrinol 2002;146:61-66.   DOI   ScienceOn
21 Bulow B, Ahren B; Swedish Research Council Study Group of Endocrine Abdominal Tumours. Adrenal incidentaloma: experience of a standardized diagnostic programme in the Swedish prospective study. J Intern Med 2002;252:239-246.   DOI   ScienceOn
22 Kasperlik-Zeluska AA, Roslonowska E, Slowinska-Srzednicka J, et al. Incidentally discovered adrenal mass (incidentaloma): investigation and management of 208 patients. Clin Endocrinol (Oxf ) 1997;46:29-37.   DOI   ScienceOn
23 Russell RP, Masi AT, Richter ED. Adrenal cortical adenomas and hypertension: a clinical pathologic analysis of 690 cases with matched controls and a review of the literature. Medicine (Baltimore) 1972;51:211-225.   DOI
24 Comlekci A, Yener S, Ertilav S, et al. Adrenal incidentaloma, clinical, metabolic, follow-up aspects: single centre experience. Endocrine 2010;37:40-46.   DOI   ScienceOn
25 Barzon L, Scaroni C, Sonino N, Fallo F, Paoletta A, Boscaro M. Risk factors and long-term follow-up of adrenal incidentalomas. J Clin Endocrinol Metab 1999;84:520- 526.
26 Terzolo M, Bovio S, Pia A, et al. Midnight serum cortisol as a marker of increased cardiovascular risk in patients with a clinically inapparent adrenal adenoma. Eur J Endocrinol 2005;153:307-315.   DOI   ScienceOn
27 Hamrahian AH, Ioachimescu AG, Remer EM, et al. Clinical utility of noncontrast computed tomography attenuation value (hounsf ield units) to differentiate adrenal adenomas/hyperplasias from nonadenomas: Cleveland Clinic experience. J Clin Endocrinol Metab 2005;90:871-877.   DOI
28 Korobkin M, Brodeur FJ, Yutzy GG, et al. Differentiation of adrenal adenomas from nonadenomas using CT attenuation values. AJR Am J Roentgenol 1996;166:531- 536.   DOI   ScienceOn
29 Cirillo RL Jr, Bennett WF, Vitellas KM, Poulos AG, Bova JG. Pathology of the adrenal gland: imaging features. AJR Am J Roentgenol 1998;170:429-435.   DOI   ScienceOn
30 Tauchmanova L, Rossi R, Biondi B, et al. Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk. J Clin Endocrinol Metab 2002;87:4872-4878.   DOI   ScienceOn
31 Rossi R, Tauchmanova L, Luciano A, et al. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features. J Clin Endocrinol Metab 2000;85:1440-1448.
32 Libe R, Dall'Asta C, Barbetta L, Baccarelli A, Beck-Peccoz P, Ambrosi B. Long-term follow-up study of patients with adrenal incidentalomas. Eur J Endocrinol 2002;147:489-494.   DOI   ScienceOn
33 Song JH, Chaudhry FS, Mayo-Smith WW. The incidental indeterminate adrenal mass on CT (> 10 H) in patients without cancer: is further imaging necessary? Follow-up of 321 consecutive indeterminate adrenal masses. AJR Am J Roentgenol 2007;189:1119-1123.   DOI
34 Young WF Jr. Clinical practice: the incidentally discovered adrenal mass. N Engl J Med 2007;356:601-610.   DOI   ScienceOn
35 Cawood TJ, Hunt PJ, O'Shea D, Cole D, Soule S. Recommended evaluation of adrenal incidentalomas is costly, has high false-positive rates and confers a risk of fatal cancer that is similar to the risk of the adrenal lesion becoming malignant: time for a rethink? Eur J Endocrinol 2009;161:513-527.   DOI   ScienceOn